GILEAD Short Term Uptrend Trade Plan
Trade Plan for Gilead Sciences.
Will look to enter at bottom of uptrend channel (75.3) , Stop Loss once uptrend broken (74).
Target Price at 86. Potential Price at 96. Personally will take profit at resistances as insurance.
Upside for Gilead:
1a) Possible treatment for Covid-19 (Remdesivir)
1b) Possible 2nd wave of virus
2) Possible FDA approval of Arthritis drug
Downside for Gilead:
1) Leaked report of Remdesivir failing in China randomized trial, which was cancelled early due to low enrollment numbers. Bears clinging on hopes that the conclusion was inaccurate due to short duration of study
Will look to enter at bottom of uptrend channel (75.3) , Stop Loss once uptrend broken (74).
Target Price at 86. Potential Price at 96. Personally will take profit at resistances as insurance.
Upside for Gilead:
1a) Possible treatment for Covid-19 (Remdesivir)
1b) Possible 2nd wave of virus
2) Possible FDA approval of Arthritis drug
Downside for Gilead:
1) Leaked report of Remdesivir failing in China randomized trial, which was cancelled early due to low enrollment numbers. Bears clinging on hopes that the conclusion was inaccurate due to short duration of study
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.